Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy

Title
Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume 1, Issue 6, Pages 373-377
Publisher
American Association for Cancer Research (AACR)
Online
2013-10-08
DOI
10.1158/2326-6066.cir-13-0092

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started